Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes

Citations Over TimeTop 1% of 2014 papers

Abstract

Early reports indicate that long non-coding RNAs (lncRNAs) are novel regulators of biological responses. However, their role in the human innate immune response, which provides the initial defence against infection, is largely unexplored. To address this issue, here we characterize the long non-coding RNA transcriptome in primary human monocytes using RNA sequencing. We identify 76 enhancer RNAs (eRNAs), 40 canonical lncRNAs, 65 antisense lncRNAs and 35 regions of bidirectional transcription (RBT) that are differentially expressed in response to bacterial lipopolysaccharide (LPS). Crucially, we demonstrate that knockdown of nuclear-localized, NF-κB-regulated, eRNAs (IL1β-eRNA) and RBT (IL1β-RBT46) surrounding the IL1β locus, attenuates LPS-induced messenger RNA transcription and release of the proinflammatory mediators, IL1β and CXCL8. We predict that lncRNAs can be important regulators of the human innate immune response.

Related Papers

• → Circulating MicroRNA and Long Noncoding RNA as Biomarkers of Cardiovascular Diseases(2015)68 cited
• → Long Noncoding RNAs in Metabolic Syndrome Related Disorders(2016)76 cited
• Biogenesis of small noncoding RNAs in escherichia coli = 대장균에서 small noncoding RNA들의 생합성에 대한 연구(2004)
• → Effects of noncoding RNA on brain function(2014)
• The dichotomy of p53 regulation by noncoding RNAs(2014)